Neuland Laboratories Limited (BOM:524558)

Neuland Laboratories Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 10, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	196,283	154,946	80,588	23,087	13,171	26,788
Market Cap Growth	92.27%	92.27%	249.07%	75.28%	-50.83%	636.62%
Enterprise Value	195,458	154,137	80,232	24,941	15,076	28,580
Last Close Price	15298.90	12076.95	6270.44	1790.15	1017.00	2065.30
PE Ratio	75.46	59.57	26.86	14.12	20.64	33.22
Forward PE	57.07	44.12	25.58	20.20	15.19	28.71
PS Ratio	13.29	10.49	5.17	1.94	1.38	2.86
PB Ratio	12.87	10.16	6.28	2.32	1.57	3.41
P/TBV Ratio	15.82	12.49	8.05	3.24	2.36	5.32
P/FCF Ratio	176.96	139.69	68.58	13.49	-	31.90
P/OCF Ratio	61.84	48.82	30.86	9.73	21.81	14.15
PEG Ratio	-	0.59	0.59	0.59	0.59	0.59
EV/Sales Ratio	13.23	10.44	5.15	2.09	1.58	3.05
EV/EBITDA Ratio	59.37	47.53	17.49	8.93	10.74	19.72
EV/EBIT Ratio	73.75	58.16	19.89	10.82	15.69	26.07
EV/FCF Ratio	176.22	138.96	68.28	14.58	-	34.04
Debt / Equity Ratio	0.10	0.10	0.07	0.13	0.29	0.23
Debt / EBITDA Ratio	0.48	0.48	0.21	0.46	1.67	1.23
Debt / FCF Ratio	1.42	1.42	0.81	0.75	-	2.17
Asset Turnover	0.74	0.74	0.91	0.80	0.70	0.73
Inventory Turnover	2.04	2.04	2.33	2.26	2.16	2.38
Quick Ratio	1.21	1.21	1.10	0.95	0.69	0.63
Current Ratio	2.45	2.45	2.15	1.73	1.60	1.49
Return on Equity (ROE)	18.53%	18.53%	26.36%	17.83%	7.85%	10.78%
Return on Assets (ROA)	8.26%	8.26%	14.77%	9.73%	4.44%	5.36%
Return on Capital (ROIC)	10.83%	10.83%	20.16%	13.08%	5.86%	7.05%
Return on Capital Employed (ROCE)	15.50%	15.50%	28.70%	20.20%	9.40%	11.50%
Earnings Yield	1.33%	1.68%	3.72%	7.08%	4.85%	3.01%
FCF Yield	0.57%	0.72%	1.46%	7.41%	-2.83%	3.13%
Dividend Yield	0.08%	0.10%	0.22%	0.56%	0.49%	0.24%
Payout Ratio	6.91%	6.91%	4.28%	3.92%	6.03%	3.18%
Total Shareholder Return	0.08%	0.10%	0.22%	0.56%	0.49%	0.24%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.